Justin K. Ma

🦠Bugs, Drugs, and Pharmacy!📍CA 🔥Passionate about stewardship, mentoring, and administration.

[Antibiotic Steward Bassam Ghanem 🅱️C🆔🅿️🌟 @ABsteward]

"Cefazolin should be the new first line standard of care treatment for MSSA bactremia" @Josh_S_Davis @syctong #ESCMIDGlobal #IDXposts

[Antibiotic Steward Bassam Ghanem 🅱️C🆔🅿️🌟 @ABsteward]

🔥A sneak peak on the upcoming IDSA guidelines for cUTI🔥
Public Comment: IDSA Guideline on Management and Treatment of Complicated Urinary Tract Infections
So it's still not published yet ! @BradSpellberg @DrToddLee
https://t.co/dyjJvCNJJ6

[Antibiotic Steward Bassam Ghanem 🅱️C🆔🅿️🌟 @ABsteward]

🔥🆕️CACTUS
@ryankshields
Multi center real world data on ceftaz/avi vs ceftol/tazo for MDR PsA bacteremia or pneumonia
Overall similar clinical success including mortality, recurrent infection & resistance #idxposts
https://t.co/OhQqd4tw9U

[SIDP @SIDPharm]

We're excited to kick off @cdc_AR Antibiotic Awareness Week! We recognize the need to fight Antimicrobial Resistance & celebrate the work of ASP/ID clinicians & researchers
Join us this #USAAW24 as we share insight & hold virtual discussion on how the Fight vs AR Takes All of Us!

[WikiGuidelines @Wiki_Guidelines]

We are delighted to announce the publication of UTI WikiGuideline in JAMA Network Open. Thank you to the 54 experts from 12 countries for drafting. Special thanks to @zacroBID and @amenalor for leading the effort.

https://t.co/XC2MgtjTdb

[Dayna McManus @Day_Mac3]

@IDWeekmtg off to a great start with an amazing @SIDPharm annual meeting catching up with new and old friends ❤️❤️❤️ @abripenem #IDPharmD #SIDP #AST #Stewardship

[Antibiotic Steward Bassam Ghanem 🅱️C🆔🅿️🌟 @ABsteward]

🔥🔥Just published🔥🔥
IDSA 2024 Guidance on the Treatment of Antimicrobial Resistant Gram-Negative Infections
@IDSAInfo @SIDPharm @julie_justo @emilylheil
Thanks @Inox94 #idxposts
https://t.co/kPfcgV8uiW

[U.S. FDA @US_FDA]

Today, we approved an injectable medication to treat adults with Staphylococcus aureus bloodstream infection; adults with acute bacterial skin and skin structure infections; and adult and pediatric patients 3 months to less than 18 years old with community-acquired bacterial pneumonia. https://t.co/0KMq4z7PqP

[SIDP @SIDPharm]

🆕 Episode of #Breakpoints: Time to arm yourselves with all the resources on antimicrobial locks! Join our experts, Drs. @CanRowPharm, @NasiaSafdar, @kidney_boy, & @julie_justo to discuss lock therapy & implementation! Funding provided by CorMedix Inc

🎧 https://t.co/ez0n3ae0fR

[SIDP @SIDPharm]

🆕#Breakpoint Episode:

Drs. Thomas Holland & @VanceFowler5 join @syctong & @ErinMcCreary to discuss the ERADICATE study & the role of ceftobiprole for the treatment of complicated SAB 🦠🩸.

Recorded live: Feb. 6th, 2024 ft. an international audience
🎧 https://t.co/ez0n3ae0fR

[Antibiotic Steward Bassam Ghanem 🅱️C🆔🅿️🌟 @ABsteward]

🔥PUBLISHED 🔥 @TheLancetInfDis
Global guideline for the diagnosis and management of cryptococcosis:an initiative of the @eurconfmedmycol & @ISHAM_Mycology in cooperation @ASMicrobiology
🌟s @boulware_dr @martinhoenigl @FungalDoc @CornelyOliver @ferryhagen
https://t.co/syEhj4yI1T

[SIDP @SIDPharm]

🆕 Episode of #Breakpoints! 😍
Drs. Bonomo, @ryankshields, & @ErinMcCreary deep dive into the world of Metallo-β-lactamases. Covers nerdiest pub trivia nuggets & key details of novel therapies including beta-lactamase inhibitors & their role for MBLs

🎧 https://t.co/quZvqDggkv

[Justin K. Ma @MaPharmLyfe]

@voRIC0nazole Same experience recently as well! But totally went better than expected haha!

[SIDP @SIDPharm]

🆕#Breakpoints Episode:

New accreditation standards making your head spin? Tune in to find out what you need to know & where to start when it comes to the NHSN Antimicrobial Resistance module & the new College of American Pathologist’s standards.

🎧 https://t.co/ez0n3ae0fR

[Justin K. Ma @MaPharmLyfe]

@ABsteward [email protected]

Thank you!

[Antibiotic Steward Bassam Ghanem 🅱️C🆔🅿️🌟 @ABsteward]

🔥🔥SABATO RCT 🔥🔥 @TheLancetInfDis
Efficacy and safety of an early oral switch in low-risk Staphylococcus aureus BSI
Oral switch antimicrobial therapy was non-inferior to IV standard therapy in participants with low-risk S aureus BSI @BradSpellberg
https://t.co/qX5gmRRpuG

[Antibiotic Steward Bassam Ghanem 🅱️C🆔🅿️🌟 @ABsteward]

A must-read article for every antibiotic steward
This perspective by @SIDPharm @emilylheil is so far one of the best articles in the series of voices of ID @CIDJournal
Put the Fluoroquinolone Down and No One Gets Hurt
Cc @IDstewardship #idxposts #stewadrs https://t.co/3np5LoxBN8

[TransplantID Journal @TheTxIDjournal]

This year’s paper is from @DrArreolaG and colleagues entitled “Treatment of asymptomatic bacteriuria in the first 2 months after kidney transplant: A controlled clinical trial.”

https://t.co/dkgEfFmojO

[Alice Han @dralicehan]

#IDTwitter
I am a big fan of the new complicated UTI guidelines
Finally! Guidelines that are focused on the things that matter: clinical outcomes, mortality.
Here we go.
@bwtrautner @Cortes_Penfield

[ACCP INFD PRN @accpinfdprn]

🚨 Guideline update alert!
Check out the 2023 SCCM & IDSA update for Evaluating New Fever in Adult Patients in the ICU https://t.co/JvKxsDktyF #IDTwitter #MedTwitter @accpcritprn